Global Institute of Stem Cell Therapy and Research (GIOSTAR)
GIOSTAR has an ability to treat several devastating Immunological diseases and Blood related diseases. These include Diabetes Type I and Type II, Lupus, Multiple Sclerosis, Crohn's disease, Vasculitis, Scleroderma, Myasthenia Gravis, Sickle Cell Anemia, Leukemia, Lymphoma, Thalassemia and developing the therapies for Alzheimer's, Autism, Anti-Aging Treatments, Parkinson's disease, Cancer, Heart and Retinal Degeneration, Amyotrophic Lateral Sclerosis, Neuropathy, Osteoarthritis, Paralysis, Strokes, Spinal Cord Injuries, Skin Burns and Spinal Muscular Atrophy (SMA). GIOSTAR is in process of opening Institutes of Regenerative Medicine and Dedicated Stem Cell Treatment hospitals/centers in Asia, Middle East, Africa, North and South America and Europe. The proposed facilities will be developed with the international support from public and private sectors grants and investments to provide stem cell based therapy for those suffering from degenerative or genetic diseases.